Rarebreed Veterinary Partners (Rarebreed), a technology-enabled veterinary services platform, has closed a new round of financing, led by existing investors Halle Capital Management and Trilantic North America, both leading private equity firms.
The investment will be used to support Rarebreed’s continued growth through the acquisition of additional veterinary hospitals and enhancements to the services it provides to the healthcare teams within its network.
Rarebreed partners with veterinary clinics to deliver best-in-class tools and solutions that enable employees to focus on providing the highest quality patient care. Established in 2018, the Company currently employs 800 people across 33 clinics in the Northeast, approximately doubling its footprint from the time of the company’s prior capital raise led by Trilantic North America in September of 2020.
“At Rarebreed, we are passionate about taking care of the people who take care of animals,” says Dan Espinal, CEO of Rarebreed Veterinary Partners. “We are excited to announce this new round of funding, which will allow us to continue providing an exceptional work experience for animal healthcare professionals in our network, while expanding our platform to reach even more people who have dedicated their professional lives to veterinary care.”
“Our goal is to allow veterinary professionals to focus on operating at the top of their profession while Rarebreed takes care of the rest,” says Sean Miller, COO of Rarebreed Veterinary Partners. “We believe this makes a significant difference not only for our patients, but also the employees within our network.”
Espinal and Miller retain meaningful equity stakes in the business and will continue to lead the Company through its next phase of growth.
“Dan and Sean’s leadership has been instrumental to Rarebreed’s rapid growth over the past three years,” says JP Gutfreund, Managing Partner at Halle Capital Management. “We have been thrilled to be part of the company’s journey and look forward to supporting its continued expansion as it seeks to improve the work experience for veterinary professionals across the country.”
“The Rarebreed team continues to impress us with the execution on its strategy and support of its partners in a high-growth environment,” says Jamie Manges, Partner at Trilantic North America.
“We are enthusiastic to support the team with additional capital to continue investing to address the rising tide of demand for animal healthcare services,” adds Ted Rosenwasser, Principal at Trilantic North America.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP provided legal advice to Rarebreed in the transaction.
